Upgrade to SI Premium - Free Trial

Tempus AI (TEM)

46.96 -2.02 (4.12%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Tempus AI launches OneOme pharmacogenomics testing nationally July 22, 2026 8:31 AM - StreetInsider Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine July 22, 2026 8:30 AM - BizWire Form 8-K Tempus AI, Inc. For: Jul 20 July 20, 2026 5:15 PM - SEC Filing Jefferies Reiterates Underperform Rating on Tempus AI Inc (TEM) July 20, 2026 4:54 PM - StreetInsider Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM) July 20, 2026 1:30 PM - StreetInsider Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction' July 20, 2026 12:51 PM - StreetInsider PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus July 20, 2026 11:55 AM - StreetInsider Needham Downgrades Personalis (PSNL) to Hold July 20, 2026 11:34 AM - StreetInsider Form 425 Tempus AI, Inc. Filed by: Tempus AI, Inc. July 20, 2026 9:05 AM - SEC Filing Form 8-K Tempus AI, Inc. For: Jul 20 July 20, 2026 9:04 AM - SEC Filing Tempus AI to acquire Personalis in $1.5B stock deal July 20, 2026 8:30 AM - StreetInsider Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform July 20, 2026 8:30 AM - BizWire Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service July 16, 2026 8:30 AM - BizWire Tempus AI Inc (TEM) PT Raised to $65 at Guggenheim July 16, 2026 6:38 AM - StreetInsider Tempus AI Inc (TEM) PT Raised to $67 at Baird July 13, 2026 7:18 AM - StreetInsider Form 4 Tempus AI, Inc. For: Jul 08 Filed by: Fukushima Ryan July 10, 2026 4:15 PM - SEC Filing Tempus to Report Second Quarter 2026 Financial Results on July 30 July 9, 2026 9:00 AM - BizWire Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan July 8, 2026 5:00 PM - SEC Filing Form 4 Tempus AI, Inc. For: Jul 06 Filed by: Fukushima Ryan July 8, 2026 4:15 PM - SEC Filing Freedom Capital Starts Tempus AI Inc (TEM) at Hold July 8, 2026 2:07 PM - StreetInsider Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan July 6, 2026 4:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: Jun 29 Filed by: LEFKOFSKY ERIC P July 1, 2026 4:15 PM - SEC Filing Freedom Capital Starts Tempus AI Inc (TEM) at Hold June 30, 2026 4:22 PM - StreetInsider Form 4 Tempus AI, Inc. For: Jun 25 Filed by: Rogers James William June 29, 2026 8:40 PM - SEC Filing Form 4 Tempus AI, Inc. For: Jun 25 Filed by: Doudna Jennifer A June 29, 2026 8:40 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P June 29, 2026 5:52 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Rogers James William June 25, 2026 4:26 PM - SEC Filing Tempus AI partners with Angiosarcoma Awareness on rare cancer data June 25, 2026 8:31 AM - StreetInsider Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers June 25, 2026 8:30 AM - BizWire Tempus publishes validation study for FDA-cleared ECG AI model June 11, 2026 8:30 AM - StreetInsider Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm June 11, 2026 8:30 AM - BizWire TD Cowen notes short interest shifts in life science tools stocks June 10, 2026 10:50 AM - StreetInsider Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing June 9, 2026 6:00 AM - BizWire Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference June 5, 2026 4:01 PM - BizWire Form 4 Tempus AI, Inc. For: Jun 01 Filed by: Epstein David R June 3, 2026 4:29 PM - SEC Filing Tempus launches open-source digital pathology consortium with Yale, MSK June 3, 2026 8:31 AM - StreetInsider Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members June 3, 2026 8:30 AM - BizWire Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM) June 2, 2026 6:50 AM - StreetInsider Wolfe Research Assumes Tempus AI Inc (TEM) at Peerperform June 1, 2026 4:23 PM - StreetInsider Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH June 1, 2026 8:30 AM - BizWire Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development May 31, 2026 8:30 AM - BizWire Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community May 30, 2026 8:30 AM - BizWire Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results May 30, 2026 8:00 AM - BizWire Form 4 Tempus AI, Inc. For: May 27 Filed by: LEFKOFSKY ERIC P May 29, 2026 4:15 PM - SEC Filing Tempus AI shares initial results from multimodal foundation model for oncology May 29, 2026 9:15 AM - StreetInsider Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology May 29, 2026 9:15 AM - BizWire Tempus receives FDA approval for tumor-only xT CDx genomic test May 29, 2026 8:15 AM - StreetInsider Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio May 29, 2026 8:15 AM - BizWire Tempus expands AI platform to six new cancer types for clinical insights May 28, 2026 8:31 AM - StreetInsider Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology May 28, 2026 8:30 AM - BizWire Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P May 27, 2026 4:45 PM - SEC Filing Tempus upgrades Hub platform with generative AI clinical tools May 27, 2026 8:34 AM - StreetInsider Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows May 27, 2026 8:33 AM - BizWire Form 4 Tempus AI, Inc. For: May 21 Filed by: Belcher Eric D May 26, 2026 9:46 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: Frederick Wayne A.I. May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: Epstein David R May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: Gottlieb Scott May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: Leonsis Theodore May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: West Nadja May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: BARRIS PETER J May 26, 2026 9:45 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 21 Filed by: Doudna Jennifer A May 26, 2026 9:45 PM - SEC Filing Tempus AI to present 37 research abstracts at 2026 ASCO meeting May 26, 2026 8:31 AM - StreetInsider Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting May 26, 2026 8:30 AM - BizWire Form 8-K Tempus AI, Inc. For: May 21 May 22, 2026 4:01 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: Polovin Andrew May 21, 2026 5:06 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: Rogers James William May 21, 2026 5:06 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: Schoenherr Thomas Edward May 21, 2026 5:06 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: Fukushima Ryan May 21, 2026 5:06 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: Bartolucci Ryan M May 21, 2026 5:06 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 19 Filed by: LEFKOFSKY ERIC P May 21, 2026 5:06 PM - SEC Filing Tempus launches ArteraAI prostate test for metastatic patients May 21, 2026 8:31 AM - StreetInsider Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use May 21, 2026 8:30 AM - BizWire Form 144 Tempus AI, Inc. Filed by: Bartolucci Ryan M May 20, 2026 5:15 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Rogers James William May 20, 2026 5:13 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Phelps Erik May 20, 2026 5:11 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward May 20, 2026 5:10 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Polovin Andrew May 20, 2026 5:07 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P May 20, 2026 5:06 PM - SEC Filing Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan May 20, 2026 5:04 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 14 Filed by: Fukushima Ryan May 15, 2026 5:03 PM - SEC Filing Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience May 14, 2026 8:30 AM - BizWire Tempus AI completes $460 million convertible notes offering May 13, 2026 6:10 AM - StreetInsider Form 8-K Tempus AI, Inc. For: May 07 May 13, 2026 6:03 AM - SEC Filing The Future of Intoxication Detection May Be in Your Voice May 11, 2026 8:30 AM - Globe NewsWire Tempus AI Inc (TEM) PT Lowered to $64 at H.C. Wainwright May 11, 2026 6:58 AM - StreetInsider Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution” May 11, 2026 6:00 AM - BizWire Tempus prices $400 million convertible notes offering May 8, 2026 1:00 AM - StreetInsider Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes May 8, 2026 1:00 AM - BizWire Form SCHEDULE 13G/A Tempus AI, Inc. Filed by: BAILLIE GIFFORD & CO May 7, 2026 10:05 AM - SEC Filing Tempus AI announces $350 million convertible notes offering May 7, 2026 7:11 AM - StreetInsider Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense May 7, 2026 7:11 AM - BizWire Form 4 Tempus AI, Inc. For: May 04 Filed by: Bartolucci Ryan M May 6, 2026 4:30 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 04 Filed by: Schoenherr Thomas Edward May 6, 2026 4:30 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 04 Filed by: Rogers James William May 6, 2026 4:30 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 04 Filed by: Polovin Andrew May 6, 2026 4:30 PM - SEC Filing Form 4 Tempus AI, Inc. For: May 04 Filed by: Fukushima Ryan May 6, 2026 4:30 PM - SEC Filing Lucent Diagnostics partners with Tempus AI for Alzheimer's blood testing May 6, 2026 8:02 AM - StreetInsider Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows May 6, 2026 8:00 AM - BizWire Tempus AI Inc (TEM) PT Lowered to $59 at Baird May 6, 2026 6:44 AM - StreetInsider Tempus AI Inc (TEM) PT Raised to $68 at TD Cowen May 6, 2026 5:57 AM - StreetInsider Form 10-Q Tempus AI, Inc. For: Mar 31 May 5, 2026 4:07 PM - SEC Filing Tempus AI, Inc (TEM) Misses Q1 EPS by 61c, provides guidance May 5, 2026 4:06 PM - StreetInsider Form 8-K Tempus AI, Inc. For: May 05 May 5, 2026 4:03 PM - SEC Filing Tempus Reports First Quarter 2026 Results May 5, 2026 4:01 PM - BizWire Form 4 Tempus AI, Inc. For: Apr 28 Filed by: LEFKOFSKY ERIC P April 30, 2026 4:31 PM - SEC Filing Tempus to Host Inaugural Investor Day on May 29, 2026 April 29, 2026 8:30 AM - BizWire Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P April 28, 2026 4:42 PM - SEC Filing Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 April 28, 2026 8:30 AM - BizWire Full Article List